NO980959L - Pyrimidin-derivater - Google Patents
Pyrimidin-derivaterInfo
- Publication number
- NO980959L NO980959L NO980959A NO980959A NO980959L NO 980959 L NO980959 L NO 980959L NO 980959 A NO980959 A NO 980959A NO 980959 A NO980959 A NO 980959A NO 980959 L NO980959 L NO 980959L
- Authority
- NO
- Norway
- Prior art keywords
- group
- substituent
- derivative
- salt
- lower alkyl
- Prior art date
Links
- 150000003230 pyrimidines Chemical class 0.000 title abstract 2
- 229940083082 pyrimidine derivative acting on arteriolar smooth muscle Drugs 0.000 title 1
- 125000001424 substituent group Chemical group 0.000 abstract 6
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 102000002045 Endothelin Human genes 0.000 abstract 1
- 108050009340 Endothelin Proteins 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 abstract 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- -1 phenyloxy group Chemical group 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 230000003639 vasoconstrictive effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP22890795 | 1995-09-06 | ||
| PCT/JP1996/002494 WO1997009318A1 (fr) | 1995-09-06 | 1996-09-04 | Derives de la pyrimidine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO980959L true NO980959L (no) | 1998-03-05 |
| NO980959D0 NO980959D0 (no) | 1998-03-05 |
| NO310235B1 NO310235B1 (no) | 2001-06-11 |
Family
ID=16883731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19980959A NO310235B1 (no) | 1995-09-06 | 1998-03-05 | Pyrimidin-derivater, anvendelse av dem og farmasöytiske blandinger inneholdende dem |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5883092A (no) |
| EP (1) | EP0852226B1 (no) |
| KR (1) | KR100453097B1 (no) |
| CN (1) | CN1105711C (no) |
| AT (1) | ATE254607T1 (no) |
| AU (1) | AU703892B2 (no) |
| CA (1) | CA2230516C (no) |
| DE (1) | DE69630799T2 (no) |
| ES (1) | ES2210384T3 (no) |
| HK (1) | HK1016591A1 (no) |
| HU (1) | HUP9903526A3 (no) |
| NO (1) | NO310235B1 (no) |
| PT (1) | PT852226E (no) |
| RU (1) | RU2170734C2 (no) |
| WO (1) | WO1997009318A1 (no) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2207100C (en) | 1994-12-28 | 2008-02-19 | Kowa Co., Ltd. | Pyrimidine derivatives |
| ID26096A (id) | 1998-03-31 | 2000-11-23 | Tanabe Seiyaku Co | Zat untuk pencegahan atau pengobatan disuria |
| CA2315614C (en) * | 1999-07-29 | 2004-11-02 | Pfizer Inc. | Pyrazoles |
| ATE316963T1 (de) * | 2000-01-25 | 2006-02-15 | Hoffmann La Roche | Herstellung von sulfonamiden |
| US6387915B2 (en) | 2000-05-31 | 2002-05-14 | Pfizer Inc. | Isoxazole-sulfonamide endothelin antagonists |
| US6670362B2 (en) | 2000-09-20 | 2003-12-30 | Pfizer Inc. | Pyridazine endothelin antagonists |
| NZ566263A (en) * | 2002-05-24 | 2009-09-25 | Millennium Pharm Inc | CCR9 inhibitors and methods of use thereof |
| WO2011078143A1 (ja) * | 2009-12-22 | 2011-06-30 | 塩野義製薬株式会社 | ピリミジン誘導体およびそれらを含有する医薬組成物 |
| US9682942B2 (en) | 2013-05-31 | 2017-06-20 | Kowa Company, Ltd. | Form of pyrimidine compound having dibenzylamine structure |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW394761B (en) * | 1993-06-28 | 2000-06-21 | Hoffmann La Roche | Novel Sulfonylamino Pyrimidines |
| IL111959A (en) * | 1993-12-17 | 2000-07-16 | Tanabe Seiyaku Co | N-(polysubstituted pyrimidin-4-yl) benzenesulfonamide derivatives their preparation and pharmaceutical compositions containing them |
| CA2207100C (en) * | 1994-12-28 | 2008-02-19 | Kowa Co., Ltd. | Pyrimidine derivatives |
-
1996
- 1996-09-04 HU HU9903526A patent/HUP9903526A3/hu unknown
- 1996-09-04 RU RU98106104/04A patent/RU2170734C2/ru not_active IP Right Cessation
- 1996-09-04 EP EP96929512A patent/EP0852226B1/en not_active Expired - Lifetime
- 1996-09-04 AU AU68890/96A patent/AU703892B2/en not_active Ceased
- 1996-09-04 PT PT96929512T patent/PT852226E/pt unknown
- 1996-09-04 DE DE69630799T patent/DE69630799T2/de not_active Expired - Lifetime
- 1996-09-04 WO PCT/JP1996/002494 patent/WO1997009318A1/ja active IP Right Grant
- 1996-09-04 AT AT96929512T patent/ATE254607T1/de not_active IP Right Cessation
- 1996-09-04 KR KR10-1998-0701163A patent/KR100453097B1/ko not_active IP Right Cessation
- 1996-09-04 CA CA002230516A patent/CA2230516C/en not_active Expired - Fee Related
- 1996-09-04 CN CN96196812A patent/CN1105711C/zh not_active Expired - Fee Related
- 1996-09-04 US US09/029,244 patent/US5883092A/en not_active Expired - Fee Related
- 1996-09-04 ES ES96929512T patent/ES2210384T3/es not_active Expired - Lifetime
-
1998
- 1998-03-05 NO NO19980959A patent/NO310235B1/no not_active IP Right Cessation
-
1999
- 1999-04-13 HK HK99101534A patent/HK1016591A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69630799D1 (en) | 2003-12-24 |
| EP0852226A1 (en) | 1998-07-08 |
| HUP9903526A2 (hu) | 2000-06-28 |
| DE69630799T2 (de) | 2004-08-12 |
| ES2210384T3 (es) | 2004-07-01 |
| RU2170734C2 (ru) | 2001-07-20 |
| CN1105711C (zh) | 2003-04-16 |
| EP0852226A4 (en) | 1998-09-02 |
| CA2230516C (en) | 2008-11-18 |
| PT852226E (pt) | 2004-03-31 |
| HK1016591A1 (en) | 1999-11-05 |
| HUP9903526A3 (en) | 2000-07-28 |
| WO1997009318A1 (fr) | 1997-03-13 |
| NO310235B1 (no) | 2001-06-11 |
| EP0852226B1 (en) | 2003-11-19 |
| AU6889096A (en) | 1997-03-27 |
| ATE254607T1 (de) | 2003-12-15 |
| AU703892B2 (en) | 1999-04-01 |
| CN1196051A (zh) | 1998-10-14 |
| CA2230516A1 (en) | 1997-03-13 |
| KR100453097B1 (ko) | 2004-12-31 |
| KR19990037684A (ko) | 1999-05-25 |
| US5883092A (en) | 1999-03-16 |
| NO980959D0 (no) | 1998-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0418845T3 (da) | Pyrazolderivater, fremgangsmåder til fremstilling deraf og farmaceutisk præparat omfattende samme | |
| DE60017115D1 (de) | Amid-derivate und deren medizinische verwendung | |
| BR9812364A (pt) | Composto, uso do mesmo, composição farmacêutica, derivado de amida, e, processo para a preparação de um derivado de amida ou de um sal farmaceuticamente aceitável ou éster clivável in vivo deste | |
| EP0767170A4 (en) | 4,6-DIARYLPYRIMIDINE DERIVATIVES AND THEIR SALTS | |
| ES2096073T3 (es) | Derivado de benzamida. | |
| ATE254607T1 (de) | Pyrimidinderivate | |
| KR960022486A (ko) | 신규 티아졸리딘-4-온 유도체 | |
| PT1157998E (pt) | Compostos heterociclicos seus intermediarios e inibidores da elastase | |
| MY141488A (en) | Hydroximic acid derivatives, processes for their preparation, and compositions comprising them | |
| ES2011427A4 (es) | Derivados de oxina de octahidronaftaleno para inhibicion de la sintesis del colesterol, procesos para su preparacion y composiciones que los contienen. | |
| DK0882728T3 (da) | 1-methylcarbapenemderivater | |
| ATE342266T1 (de) | 1-methylcarbapenemderivate | |
| EP1252890A4 (en) | MEDICINAL AND PREVENTIVE AGENTS FOR DIGESTIVE DISEASES CONTAINING DIAMINOTRIFLUOROMETHYLPYRIDINE COMPOUNDS | |
| ES2196090T3 (es) | Derivados pirimidinicos. | |
| ATE504572T1 (de) | Derivate von aromatische heterocyclen enthaltende integraseinhibitoren | |
| PT1209166E (pt) | Novos derivados de a-500359 | |
| DK0501354T3 (da) | Antikataraktmiddel | |
| NO20004798L (no) | Barbitursyrederivat og forebyggende og terapeutisk middel for ben og brusk inneholdende det samme | |
| DE69722630D1 (de) | Therapeutisches mittel zur behandlung von nierenerkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |